CAV1 and neoplasm: Gene therapy, using viral vectors or CRISPR/Cas9-based systems, may restore Cav-1 expression in tumor-suppressive contexts, while RNA-based therapies (e.g., siRNA or miRNA) could inhibit Cav-1 expression in cancers where it functions as an oncogene.